GlassScriptPhysician profile
Steven C Cordero
NPI 1821259862
$61,864.90
in general payments reported to CMS, 2019-2025
5 companies · $72.08 in 2025
The $72.08 reported for 2025 was more than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $7,775 · 2021: $3,500 · 2022: $20K · 2023: $15K · 2024: $15K · 2025: $72.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,974.54 |
| Food and Beverage | $215.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $61,649.54 | 2020-2024 | |
| Neurocrine Biosciences, INC. | $128.09 | 2023 | Ingrezza |
| Roche Diagnostics Corporation | $49.32 | 2024-2025 | Virtuoso System For Ihc |
| Tempus Ai, INC | $20.11 | 2025 | Xt Cdx |
| Boston Scientific Corporation | $17.84 | 2025 | Opticross 35 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Cordero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.